Literature DB >> 8951881

Brain distribution of nitric oxide synthase in neuronal or endothelial nitric oxide synthase mutant mice using [3H]L-NG-nitro-arginine autoradiography.

H Hara1, C Waeber, P L Huang, M Fujii, M C Fishman, M A Moskowitz.   

Abstract

The regional distribution of nitric oxide synthase in the central nervous system was assessed by quantitative autoradiography using [3H]L-NG-nitro-arginine binding in wild-type mice (SV-129 and C57black/6) and in mice lacking expression of the neuronal (type 1) and endothelial (type 3) nitric oxide synthase gene. The distribution of nitric oxide synthase binding sites in wild-type mice was similar to that described for rat brain by nicotinamide adenine dinucleotide phosphate-diaphorase staining and immunohistochemistry, and as determined by quantitative autoradiography. In the wild-type mice, the densest labelling was observed in the granular layer of the olfactory bulb, tenia tecta, rhinal fissure, amygdaloid complex and molecular layer of cerebellum. The islands of Calleja, the hippocampal CA1 and CA3 subfields, dentate gyrus, cortical layers I-II, the superficial gray layer of superior colliculus and the granule layer of cerebellum displayed intermediate binding. Cortical layers III-VI, the striatum and the thalamus were only weakly labelled. Binding was saturable and of high affinity, and was displaced by 7-nitroindazole (100 microM), a potent and selective inhibitor of type 1 nitric oxide synthase, and by unlabelled L-NG-nitro-arginine (10 microM). The density of [3H]L-NG-nitro-arginine binding was dramatically reduced in all brain regions in type 1 mutant mice, whereas there were no detectable binding differences between wild-type and type 3 nitric oxide synthase mutant mice. Hence, type 1 nitric oxide synthase is the major source of [3H]L-NG-nitro-arginine binding in the mouse brain. [3H]L-NG-Nitro-arginine autoradiography may be a useful tool to quantify nitric oxide synthase in different brain areas after pharmacological or physiological manipulations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8951881     DOI: 10.1016/0306-4522(96)00313-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  12 in total

1.  Effects of blockade of glutamate NMDA receptors or of NO synthase on the development or the expression of associative or non-associative sensitization to locomotor activation by morphine.

Authors:  A Atalla; K Kuschinsky
Journal:  J Neural Transm (Vienna)       Date:  2005-04-22       Impact factor: 3.575

2.  Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation.

Authors:  Dean A Le; Yongqin Wu; Zhihong Huang; Kohji Matsushita; Nikolaus Plesnila; Jean C Augustinack; Bradley T Hyman; Junying Yuan; Keisuke Kuida; Richard A Flavell; Michael A Moskowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

3.  Evidence for involvement of the cGMP-protein kinase G signaling system in the induction of long-term depression, but not long-term potentiation, in the dentate gyrus in vitro.

Authors:  J Wu; Y Wang; M J Rowan; R Anwyl
Journal:  J Neurosci       Date:  1998-05-15       Impact factor: 6.167

Review 4.  Role of endothelial nitric oxide in cerebrovascular regulation.

Authors:  Dmitriy N Atochin; Paul L Huang
Journal:  Curr Pharm Biotechnol       Date:  2011-09       Impact factor: 2.837

5.  Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage.

Authors:  M J Eliasson; Z Huang; R J Ferrante; M Sasamata; M E Molliver; S H Snyder; M A Moskowitz
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

6.  Superior water maze performance and increase in fear-related behavior in the endothelial nitric oxide synthase-deficient mouse together with monoamine changes in cerebellum and ventral striatum.

Authors:  C Frisch; E Dere; M A Silva; A Godecke; J Schrader; J P Huston
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

7.  Opposite effects of milnacipran, a serotonin norepinephrine reuptake inhibitor, on the levels of nitric oxide and brain-derived neurotrophic factor in mouse brain cortex.

Authors:  Atsuko Ikenouchi-Sugita; Yumiko Toyohira; Reiji Yoshimura; Susumu Ueno; Masato Tsutsui; Jun Nakamura; Nobuyuki Yanagihara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-06       Impact factor: 3.000

8.  Blockade of tetrahydrobiopterin synthesis protects neurons after transient forebrain ischemia in rat: a novel role for the cofactor.

Authors:  S Cho; B T Volpe; Y Bae; O Hwang; H J Choi; J Gal; L C Park; C K Chu; J Du; T H Joh
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

9.  Effects of restraint stress and nitric oxide synthase inhibition on learning and strategy preference in young adult male rats.

Authors:  Melih Dağdeviren; Yusuf Hakan Doğan; Lütfiye Kanıt
Journal:  Balkan Med J       Date:  2012-12-01       Impact factor: 2.021

Review 10.  Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects.

Authors:  Regina F Nasyrova; Dmitriy V Ivashchenko; Mikhail V Ivanov; Nikolay G Neznanov
Journal:  Front Physiol       Date:  2015-05-11       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.